Post Reply
1881-1900 of 1914
More brushing today..... smile leh......
bishan22 ( Date: 19-Apr-2016 09:32) Posted:
Break out..................
bishan22 ( Date: 17-Apr-2016 10:45) Posted:
Just above 20 MA..... watch first....
|
|
|
|
if ipo of 2 china subsidary, then should up a lot.........should be 80 cents soon
Break out..................
bishan22 ( Date: 17-Apr-2016 10:45) Posted:
Just above 20 MA..... watch first....
|
|
It is dropping today....
If Q& M subsidary get listed in china, perhaps it will have a re rating....else seems down now......
Good things do not come cheap because nobody wants to sell out cheap. Just have to keep waiting if one wants it cheap and dun know whether the time will come for it may not come at all. And the longer the wait, the more one loses out on the opportunity cost as the missed boat would have upgraded to a better ship and is sailing further and further out into the seas to explore and open more new grounds for the better. Haha. :)
jamesng ( Date: 14-Apr-2016 15:04) Posted:
Q & M 3 year CAGR is 36% and ROE is 17%.
spore1 ( Date: 10-Mar-2016 23:20) Posted:
at current price of 66 cents the PE is 45 times. Seem rather expensive. DYODD . Be extra careful.
|
|
|
|
good takeaways published in Phillip' s latest report, published on NextInsight:
http://www.nextinsight.net/index.php/story-archive-mainmenu-60/938-2016/10683-q-m-dental-losses-and-gains-from-spin-off-of-china-subsidiary
interestingly, the share price has been trading very flat for almost the last 6 months...personally a customer of Q& M. while service is good, prices arent cheap.
pe 45 is crazy xia.
invest for wat.
spore1 ( Date: 10-Mar-2016 23:20) Posted:
at current price of 66 cents the PE is 45 times. Seem rather expensive. DYODD . Be extra careful.
jessliew ( Date: 10-Mar-2016 20:35) Posted:
Q& M full-year profit up as acquisitions boost revenue
By Lee Meixian
Q& M Dental Group has posted a 33 per cent increase in its net profit to S$11.4 million for its full year ended Dec 31, 2015. Revenue was up 16 per cent at S$97.8 million. Earnings per share rose to 1.46 Singapore cents, from 1.2 Singapore cents a year ago.
The group said the increase in revenue from its dental and medical clinics was partly due to new dental outlets in Singapore. Some of these came from the acquisitions of TP Dental Surgeons, Tiong Bahru Dental Surgery and Bright Smile Dental Surgery in September 2015, as well as the acquisition of Aesthetics Dental Surgery in November 2015. In China, Q& M saw revenue contribution from Aoxin, which it acquired in July 2014.
The period also saw " other gains" amounting to S$3.8 million compared with S$1 million in FY14. This was mainly due to the recognition of enhanced special employment credit, PIC (Productivity and Innovation Credit Scheme) cash payout and gain on disposal of the Jurong Gateway property, said Q& M.
As at the end of 2015, the group has a total of 65 dental outlets, three medical outlets and one aesthetic centre in operation, compared with 60 dental outlets, one mobile dental clinic, three medical outlets, one aesthetic centre and two specialist medical clinics at the end of 2014 in Singapore. Its overseas presence stayed unchanged at eight dental outlets in Malaysia and three dental hospitals and four dental outlets in China.
|
|
|
|
Just above 20 MA..... watch first....
Q & M 3 year CAGR is 36% and ROE is 17%.
spore1 ( Date: 10-Mar-2016 23:20) Posted:
at current price of 66 cents the PE is 45 times. Seem rather expensive. DYODD . Be extra careful.
jessliew ( Date: 10-Mar-2016 20:35) Posted:
Q& M full-year profit up as acquisitions boost revenue
By Lee Meixian
Q& M Dental Group has posted a 33 per cent increase in its net profit to S$11.4 million for its full year ended Dec 31, 2015. Revenue was up 16 per cent at S$97.8 million. Earnings per share rose to 1.46 Singapore cents, from 1.2 Singapore cents a year ago.
The group said the increase in revenue from its dental and medical clinics was partly due to new dental outlets in Singapore. Some of these came from the acquisitions of TP Dental Surgeons, Tiong Bahru Dental Surgery and Bright Smile Dental Surgery in September 2015, as well as the acquisition of Aesthetics Dental Surgery in November 2015. In China, Q& M saw revenue contribution from Aoxin, which it acquired in July 2014.
The period also saw " other gains" amounting to S$3.8 million compared with S$1 million in FY14. This was mainly due to the recognition of enhanced special employment credit, PIC (Productivity and Innovation Credit Scheme) cash payout and gain on disposal of the Jurong Gateway property, said Q& M.
As at the end of 2015, the group has a total of 65 dental outlets, three medical outlets and one aesthetic centre in operation, compared with 60 dental outlets, one mobile dental clinic, three medical outlets, one aesthetic centre and two specialist medical clinics at the end of 2014 in Singapore. Its overseas presence stayed unchanged at eight dental outlets in Malaysia and three dental hospitals and four dental outlets in China.
|
|
|
|
Finally up abit.. Hope can reach 70c soon
at current price of 66 cents the PE is 45 times. Seem rather expensive. DYODD . Be extra careful.
jessliew ( Date: 10-Mar-2016 20:35) Posted:
Q& M full-year profit up as acquisitions boost revenue
By Lee Meixian
Q& M Dental Group has posted a 33 per cent increase in its net profit to S$11.4 million for its full year ended Dec 31, 2015. Revenue was up 16 per cent at S$97.8 million. Earnings per share rose to 1.46 Singapore cents, from 1.2 Singapore cents a year ago.
The group said the increase in revenue from its dental and medical clinics was partly due to new dental outlets in Singapore. Some of these came from the acquisitions of TP Dental Surgeons, Tiong Bahru Dental Surgery and Bright Smile Dental Surgery in September 2015, as well as the acquisition of Aesthetics Dental Surgery in November 2015. In China, Q& M saw revenue contribution from Aoxin, which it acquired in July 2014.
The period also saw " other gains" amounting to S$3.8 million compared with S$1 million in FY14. This was mainly due to the recognition of enhanced special employment credit, PIC (Productivity and Innovation Credit Scheme) cash payout and gain on disposal of the Jurong Gateway property, said Q& M.
As at the end of 2015, the group has a total of 65 dental outlets, three medical outlets and one aesthetic centre in operation, compared with 60 dental outlets, one mobile dental clinic, three medical outlets, one aesthetic centre and two specialist medical clinics at the end of 2014 in Singapore. Its overseas presence stayed unchanged at eight dental outlets in Malaysia and three dental hospitals and four dental outlets in China.
|
|
Q& M full-year profit up as acquisitions boost revenue
By Lee Meixian
Q& M Dental Group has posted a 33 per cent increase in its net profit to S$11.4 million for its full year ended Dec 31, 2015. Revenue was up 16 per cent at S$97.8 million. Earnings per share rose to 1.46 Singapore cents, from 1.2 Singapore cents a year ago.
The group said the increase in revenue from its dental and medical clinics was partly due to new dental outlets in Singapore. Some of these came from the acquisitions of TP Dental Surgeons, Tiong Bahru Dental Surgery and Bright Smile Dental Surgery in September 2015, as well as the acquisition of Aesthetics Dental Surgery in November 2015. In China, Q& M saw revenue contribution from Aoxin, which it acquired in July 2014.
The period also saw " other gains" amounting to S$3.8 million compared with S$1 million in FY14. This was mainly due to the recognition of enhanced special employment credit, PIC (Productivity and Innovation Credit Scheme) cash payout and gain on disposal of the Jurong Gateway property, said Q& M.
As at the end of 2015, the group has a total of 65 dental outlets, three medical outlets and one aesthetic centre in operation, compared with 60 dental outlets, one mobile dental clinic, three medical outlets, one aesthetic centre and two specialist medical clinics at the end of 2014 in Singapore. Its overseas presence stayed unchanged at eight dental outlets in Malaysia and three dental hospitals and four dental outlets in China.
Balancing positions or speculating if there are no news.
jessliew ( Date: 07-Mar-2016 10:48) Posted:
| Hmm how come qnm keep going down since the quarter result come out? The result is pretty good.. |
|
Hmm how come qnm keep going down since the quarter result come out? The result is pretty good..
You are welcomed ecekca! :)
ecekca ( Date: 04-Mar-2016 15:22) Posted:
Good stuff . U r right
Their leader is poor . That why they never managed to turnaround.
jeremyow ( Date: 04-Mar-2016 10:20) Posted:
Healthway Medical Corp' s financial performace loses out to Raffles Medical Corp. Even though the former is one of the leading medical and healthcare groups in Singapore with a very large number of medical and dental clinics currently, the group does not seem to perform well in terms of its financials, Its revenue has been growing through the years with mostly single digits growth yearly on yearly. However it pales in comparison with its peers such as Raffles Medical Corp and Q & M Dental Group which can command double digits growth in its revenue. Furthermore, Healthway' s operating profits (excluding extraordinary items) have been rocky through the years with some years having earning losses. As such, it has accumulated losses on its balance sheet abeit that the accumulated losses has decreased slowly through the years. However, it still manages to bring in positive cashflows through the years.
Fast forward to its most recent financial performance, its operating profits has decreased significantly yearly on yearly by 72.9% from FY2014 to FY2015. The EPS for FY2015 is $0.0007 as compared to FY2014 of $0.0043 which is a decrease of 83.7% yearly on yearly. This is quite a drastic decrease of more than half (50%) of its previous year' s operating profits. Its current PE ratio in the 40s is high not because of rising share price but because of the drastic decrease in its EPS for FY2015. Thus, do be careful not to just rely on PE ratio at surface value but investigate why a company is having high PE ratio. It could well be that its operating profits and EPS has decreased significantly yearly on yearly even though its share price has not increased.
What do all these rocky financial figures through the past decade show us? The answer is quite obvious. Even though the group had expanded its operations in terms of number of medical and dental clinics in Singapore and China increasing its revenue at only a modest pace, its operations seems not to be bringing in parallel growth in profits and even suffered losses on some years. This could suggest difficulty and lack in managing costs for this medical and healthcare group even as it is making just modest growth on its revenue. As such, the return on shareholder equity (ROE at best single digit or negative on some years) is not much to be desired even if this medical and healthcare group has been expanding its operations. This also tells us that even if an industry is good such as healthcare industry with its defensive nature, there are different players in the industry and each player may perform differently even if their nature of operations are very similar.
A remaining question to ask is will this medical and healthcare operator improve in its business in future? Well, we shall have to wait for a while and see. As of now, its past financial performance (for at least the past decade) does not interest me as an investor to consider taking a closer look at this medical and healthcare group.
|
|
|
|
Good stuff . U r right
Their leader is poor . That why they never managed to turnaround.
jeremyow ( Date: 04-Mar-2016 10:20) Posted:
Healthway Medical Corp' s financial performace loses out to Raffles Medical Corp. Even though the former is one of the leading medical and healthcare groups in Singapore with a very large number of medical and dental clinics currently, the group does not seem to perform well in terms of its financials, Its revenue has been growing through the years with mostly single digits growth yearly on yearly. However it pales in comparison with its peers such as Raffles Medical Corp and Q & M Dental Group which can command double digits growth in its revenue. Furthermore, Healthway' s operating profits (excluding extraordinary items) have been rocky through the years with some years having earning losses. As such, it has accumulated losses on its balance sheet abeit that the accumulated losses has decreased slowly through the years. However, it still manages to bring in positive cashflows through the years.
Fast forward to its most recent financial performance, its operating profits has decreased significantly yearly on yearly by 72.9% from FY2014 to FY2015. The EPS for FY2015 is $0.0007 as compared to FY2014 of $0.0043 which is a decrease of 83.7% yearly on yearly. This is quite a drastic decrease of more than half (50%) of its previous year' s operating profits. Its current PE ratio in the 40s is high not because of rising share price but because of the drastic decrease in its EPS for FY2015. Thus, do be careful not to just rely on PE ratio at surface value but investigate why a company is having high PE ratio. It could well be that its operating profits and EPS has decreased significantly yearly on yearly even though its share price has not increased.
What do all these rocky financial figures through the past decade show us? The answer is quite obvious. Even though the group had expanded its operations in terms of number of medical and dental clinics in Singapore and China increasing its revenue at only a modest pace, its operations seems not to be bringing in parallel growth in profits and even suffered losses on some years. This could suggest difficulty and lack in managing costs for this medical and healthcare group even as it is making just modest growth on its revenue. As such, the return on shareholder equity (ROE at best single digit or negative on some years) is not much to be desired even if this medical and healthcare group has been expanding its operations. This also tells us that even if an industry is good such as healthcare industry with its defensive nature, there are different players in the industry and each player may perform differently even if their nature of operations are very similar.
A remaining question to ask is will this medical and healthcare operator improve in its business in future? Well, we shall have to wait for a while and see. As of now, its past financial performance (for at least the past decade) does not interest me as an investor to consider taking a closer look at this medical and healthcare group.
ecekca ( Date: 03-Mar-2016 20:42) Posted:
Looks like u expert in healthcare
Care to tell me the difference btw healthway and raffles. Y one is underperforminh |
|
|
|
Healthway Medical Corp' s financial performace loses out to Raffles Medical Corp. Even though the former is one of the leading medical and healthcare groups in Singapore with a very large number of medical and dental clinics currently, the group does not seem to perform well in terms of its financials, Its revenue has been growing through the years with mostly single digits growth yearly on yearly. However it pales in comparison with its peers such as Raffles Medical Corp and Q & M Dental Group which can command double digits growth in its revenue. Furthermore, Healthway' s operating profits (excluding extraordinary items) have been rocky through the years with some years having earning losses. As such, it has accumulated losses on its balance sheet abeit that the accumulated losses has decreased slowly through the years. However, it still manages to bring in positive cashflows through the years.
Fast forward to its most recent financial performance, its operating profits has decreased significantly yearly on yearly by 72.9% from FY2014 to FY2015. The EPS for FY2015 is $0.0007 as compared to FY2014 of $0.0043 which is a decrease of 83.7% yearly on yearly. This is quite a drastic decrease of more than half (50%) of its previous year' s operating profits. Its current PE ratio in the 40s is high not because of rising share price but because of the drastic decrease in its EPS for FY2015. Thus, do be careful not to just rely on PE ratio at surface value but investigate why a company is having high PE ratio. It could well be that its operating profits and EPS has decreased significantly yearly on yearly even though its share price has not increased.
What do all these rocky financial figures through the past decade show us? The answer is quite obvious. Even though the group had expanded its operations in terms of number of medical and dental clinics in Singapore and China increasing its revenue at only a modest pace, its operations seems not to be bringing in parallel growth in profits and even suffered losses on some years. This could suggest difficulty and lack in managing costs for this medical and healthcare group even as it is making just modest growth on its revenue. As such, the return on shareholder equity (ROE at best single digit or negative on some years) is not much to be desired even if this medical and healthcare group has been expanding its operations. This also tells us that even if an industry is good such as healthcare industry with its defensive nature, there are different players in the industry and each player may perform differently even if their nature of operations are very similar.
A remaining question to ask is will this medical and healthcare operator improve in its business in future? Well, we shall have to wait for a while and see. As of now, its past financial performance (for at least the past decade) does not interest me as an investor to consider taking a closer look at this medical and healthcare group.
ecekca ( Date: 03-Mar-2016 20:42) Posted:
Looks like u expert in healthcare
Care to tell me the difference btw healthway and raffles. Y one is underperforminh ?
jeremyow ( Date: 03-Mar-2016 17:49) Posted:
Having said that, good healthcare companies may also remain highly priced in their PE ratio for a very good long time. An example is Raffles Medical Group which has been constantly enjoying a high PE ratio of 20 to 40 range for very much of its time since public listed. Raffles Medical Group' s shares was listed during IPO in 1997 at $0.38 per share. Fast forward to today 19 years later, its share price is $4.43. An estimated calculation on the cumulative annual growth rate (CAGR) of Raffles Medical Group just solely on the performance of its share price is around 13.9% per annum. This does not include any dividends collected so far. If we add in the total accumulated dividends a shareholder has collected over the past 19 years since its IPO, the CAGR is definitely higher than 13.9% per annum. Thus, there is a good reason why shares of healthcare companies particularly good ones are consistently traded at high PE ratios because they have proven themselves over time to be solid good investments generating high CAGR for their shareholders.
|
|
|
|
Looks like u expert in healthcare
Care to tell me the difference btw healthway and raffles. Y one is underperforminh ?
jeremyow ( Date: 03-Mar-2016 17:49) Posted:
Having said that, good healthcare companies may also remain highly priced in their PE ratio for a very good long time. An example is Raffles Medical Group which has been constantly enjoying a high PE ratio of 20 to 40 range for very much of its time since public listed. Raffles Medical Group' s shares was listed during IPO in 1997 at $0.38 per share. Fast forward to today 19 years later, its share price is $4.43. An estimated calculation on the cumulative annual growth rate (CAGR) of Raffles Medical Group just solely on the performance of its share price is around 13.9% per annum. This does not include any dividends collected so far. If we add in the total accumulated dividends a shareholder has collected over the past 19 years since its IPO, the CAGR is definitely higher than 13.9% per annum. Thus, there is a good reason why shares of healthcare companies particularly good ones are consistently traded at high PE ratios because they have proven themselves over time to be solid good investments generating high CAGR for their shareholders.
jeremyow ( Date: 03-Mar-2016 11:00) Posted:
Q & M' s valuation is all along already high (PE ratio of 30 to 40) which most people with a bit of fundamental knowledge knows. Such growth stock are traded high for a good reason that investors think the company is growing well with double digit growth in its revenue and net profits yearly on yearly. The risk with investing in such growth stock is not that the company will face problems with survival in its businesses but rather whether it can continue to promise good growth in its revenue and earnings. Q & M in fact is now a household name and most people you ask on the streets know of this dental group as its number of dental clinics just in Singapore alone is a sizeable number and visible to the public.
The fact that it can continue to grow its number of dental clinics locally and overseas be it organically or through aquisitions and also prominent dental practitioners have came in to join this group shows its strength both financially and also in its brand. However, the risk is that since it has been performing well in its growth, practice and financials so far, any misses on the estimates of its future revenue and earnings growth may result in a market reaction with some investors selling its shares. So, a high growth company is as good as it is if it can continue to maintain its high growth. I believe there will come a time when Q & M will reach its full potential and growth will taper down to a more realistic figure in the range of single digits. Until then, its PE ratio will naturally come down to a more realistic range rather than the premium it commands now at between 30 to 40.
When will it reach its full potential and a more realistic growth figure in its revenue and net profits? Well, I think it maybe quite sometime down the road as this group is currently still aggressively expanding organically through opening more dental clinics locally and overseas and also acquiring other smaller dental companies (locally and overseas) and dental related equipments manufacturing and distribution companies. But surely there will come a day when growth tapers to a more sustainable figure and PE ratio will come down to more realistic figure as well when a company has reached its full potential and maturity and there will be not much further room for high growth.
|
|
|
|
Having said that, good healthcare companies may also remain highly priced in their PE ratio for a very good long time. An example is Raffles Medical Group which has been constantly enjoying a high PE ratio of 20 to 40 range for very much of its time since public listed. Raffles Medical Group' s shares was listed during IPO in 1997 at $0.38 per share. Fast forward to today 19 years later, its share price is $4.43. An estimated calculation on the cumulative annual growth rate (CAGR) of Raffles Medical Group just solely on the performance of its share price is around 13.9% per annum. This does not include any dividends collected so far. If we add in the total accumulated dividends a shareholder has collected over the past 19 years since its IPO, the CAGR is definitely higher than 13.9% per annum. Thus, there is a good reason why shares of healthcare companies particularly good ones are consistently traded at high PE ratios because they have proven themselves over time to be solid good investments generating high CAGR for their shareholders.
jeremyow ( Date: 03-Mar-2016 11:00) Posted:
Q & M' s valuation is all along already high (PE ratio of 30 to 40) which most people with a bit of fundamental knowledge knows. Such growth stock are traded high for a good reason that investors think the company is growing well with double digit growth in its revenue and net profits yearly on yearly. The risk with investing in such growth stock is not that the company will face problems with survival in its businesses but rather whether it can continue to promise good growth in its revenue and earnings. Q & M in fact is now a household name and most people you ask on the streets know of this dental group as its number of dental clinics just in Singapore alone is a sizeable number and visible to the public.
The fact that it can continue to grow its number of dental clinics locally and overseas be it organically or through aquisitions and also prominent dental practitioners have came in to join this group shows its strength both financially and also in its brand. However, the risk is that since it has been performing well in its growth, practice and financials so far, any misses on the estimates of its future revenue and earnings growth may result in a market reaction with some investors selling its shares. So, a high growth company is as good as it is if it can continue to maintain its high growth. I believe there will come a time when Q & M will reach its full potential and growth will taper down to a more realistic figure in the range of single digits. Until then, its PE ratio will naturally come down to a more realistic range rather than the premium it commands now at between 30 to 40.
When will it reach its full potential and a more realistic growth figure in its revenue and net profits? Well, I think it maybe quite sometime down the road as this group is currently still aggressively expanding organically through opening more dental clinics locally and overseas and also acquiring other smaller dental companies (locally and overseas) and dental related equipments manufacturing and distribution companies. But surely there will come a day when growth tapers to a more sustainable figure and PE ratio will come down to more realistic figure as well when a company has reached its full potential and maturity and there will be not much further room for high growth.
ecekca ( Date: 03-Mar-2016 09:07) Posted:
Updated: 08:45, 3 Mar' 16
CapitaLand 3.100 +0.03
Global Logistic 1.844 -0.016
ComfortDelGro 3.026 +0.016
CapitaMall Trust 2.210 +0.05
SGX 7.362 -0.018
JMH USD 57.305 +0.285
Venture 8.238 -0.002
CityDev 7.600 -0.07
DBXT Vietnam US$X@ 22.026 -0.074
SingTelMBePW160504@ 0.000 0.00
Maruwa Yen1k 0.000 0.00
Low Keng Huat 0.000 0.00
Trek 2000 Intl 0.000 0.00
China New Town^ 0.000 0.00
ElektromotW200505 0.000 0.00
Global Inv 0.000 0.00
CN8000MBePW160629@ 0.000 0.00
Chiwayland Intl^ 0.000 0.00
Sino Techfibre 0.000 0.00
STI 2900MBeCW160630@ 0.000 0.00
By PC Lee / theedgemarkets.com | March 3, 2016 : 8:41 AM MYT
  
Translated by Google Translator:
SINGAPORE (March 3): CIMB is downgrading Q& M Dental Group to &ldquo reduce&rdquo from &ldquo add&rdquo and cutting the target price to 64 cents from 84 cents, citing high valuations.
The dental-care provider posted a 43% drop in fourth-quarter core net profit which was &ldquo very disappointing,&rdquo says CIMB, adding that the valuation looks rich compared with the sector average.
Q& M Dental closed at 70 cents on Wednesday.
|
|
|
|
Q & M' s valuation is all along already high (PE ratio of 30 to 40) which most people with a bit of fundamental knowledge knows. Such growth stock are traded high for a good reason that investors think the company is growing well with double digit growth in its revenue and net profits yearly on yearly. The risk with investing in such growth stock is not that the company will face problems with survival in its businesses but rather whether it can continue to promise good growth in its revenue and earnings. Q & M in fact is now a household name and most people you ask on the streets know of this dental group as its number of dental clinics just in Singapore alone is a sizeable number and visible to the public.
The fact that it can continue to grow its number of dental clinics locally and overseas be it organically or through aquisitions and also prominent dental practitioners have came in to join this group shows its strength both financially and also in its brand. However, the risk is that since it has been performing well in its growth, practice and financials so far, any misses on the estimates of its future revenue and earnings growth may result in a market reaction with some investors selling its shares. So, a high growth company is as good as it is if it can continue to maintain its high growth. I believe there will come a time when Q & M will reach its full potential and growth will taper down to a more realistic figure in the range of single digits. Until then, its PE ratio will naturally come down to a more realistic range rather than the premium it commands now at between 30 to 40.
When will it reach its full potential and a more realistic growth figure in its revenue and net profits? Well, I think it maybe quite sometime down the road as this group is currently still aggressively expanding organically through opening more dental clinics locally and overseas and also acquiring other smaller dental companies (locally and overseas) and dental related equipments manufacturing and distribution companies. But surely there will come a day when growth tapers to a more sustainable figure and PE ratio will come down to more realistic figure as well when a company has reached its full potential and maturity and there will be not much further room for high growth.
ecekca ( Date: 03-Mar-2016 09:07) Posted:
Updated: 08:45, 3 Mar' 16
CapitaLand 3.100 +0.03
Global Logistic 1.844 -0.016
ComfortDelGro 3.026 +0.016
CapitaMall Trust 2.210 +0.05
SGX 7.362 -0.018
JMH USD 57.305 +0.285
Venture 8.238 -0.002
CityDev 7.600 -0.07
DBXT Vietnam US$X@ 22.026 -0.074
SingTelMBePW160504@ 0.000 0.00
Maruwa Yen1k 0.000 0.00
Low Keng Huat 0.000 0.00
Trek 2000 Intl 0.000 0.00
China New Town^ 0.000 0.00
ElektromotW200505 0.000 0.00
Global Inv 0.000 0.00
CN8000MBePW160629@ 0.000 0.00
Chiwayland Intl^ 0.000 0.00
Sino Techfibre 0.000 0.00
STI 2900MBeCW160630@ 0.000 0.00
By PC Lee / theedgemarkets.com | March 3, 2016 : 8:41 AM MYT
Translated by Google Translator:
SINGAPORE (March 3): CIMB is downgrading Q& M Dental Group to &ldquo reduce&rdquo from &ldquo add&rdquo and cutting the target price to 64 cents from 84 cents, citing high valuations.
The dental-care provider posted a 43% drop in fourth-quarter core net profit which was &ldquo very disappointing,&rdquo says CIMB, adding that the valuation looks rich compared with the sector average.
Q& M Dental closed at 70 cents on Wednesday.
|
|
Select Language